Peer Review History
| Original SubmissionJanuary 15, 2025 |
|---|
|
PONE-D-24-58562A cross-cultural investigation of the short version of the Celebrity Attitude Scale (CAS-7) across five countriesPLOS ONE Dear Dr. Zsila, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Osmond Ekwebelem Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript. 3. Thank you for stating the following financial disclosure: “Reza Shabahang is supported by the Australian Government Research Training Program Scholarship (AGRTPS). This funding source has no role in covering the publication fee as it is used for an individual training program which does not cover APCs.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in your Competing Interests section: “NO” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 5. In this instance it seems there may be acceptable restrictions in place that prevent the public sharing of your minimal data. However, in line with our goal of ensuring long-term data availability to all interested researchers, PLOS’ Data Policy states that authors cannot be the sole named individuals responsible for ensuring data access (http://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-sharing-methods). Data requests to a non-author institutional point of contact, such as a data access or ethics committee, helps guarantee long term stability and availability of data. Providing interested researchers with a durable point of contact ensures data will be accessible even if an author changes email addresses, institutions, or becomes unavailable to answer requests. Before we proceed with your manuscript, please also provide non-author contact information (phone/email/hyperlink) for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If no institutional body is available to respond to requests for your minimal data, please consider if there any institutional representatives who did not collaborate in the study, and are not listed as authors on the manuscript, who would be able to hold the data and respond to external requests for data access? If so, please provide their contact information (i.e., email address). Please also provide details on how you will ensure persistent or long-term data storage and availability. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 7. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 8. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files. Additional Editor Comments: • Some sentences are unnecessarily long and complex. Breaking them down would improve readability. Example: "Therefore, based on the findings by Zsila et al. (14), the CAS-7 is fundamentally unidimensional with some multidimensionality." Simplify or rephrase to avoid confusion between "fundamentally unidimensional" and "some multidimensionality." • Some minor errors, like missing commas or awkward phrasing. Examples: o Line 8: "Cronbach’s 123 alphas" = Should just be "Cronbach’s alphas." o Line 9: "which have been generally used in celebrity worship research." It could be smoother as "which are commonly used in celebrity worship research." • Terms like "cross-cultural setting" and "applicability" are repeated multiple times. Consider varying word choice slightly for flow. • While you hint at cultural differences (e.g., McCutcheon et al. finding differences between U.S. and India), you don't explain why cultural context might impact celebrity worship. Briefly explaining this would better justify the need for cross-cultural validation. • The transition to study aims feels a little abrupt. A bridge sentence summarizing why cross-cultural validation is needed based on previous limitations could strengthen it. Questions for the Authors on introduction: • How were the five countries (Canada, Hungary, Indonesia, Iran, and the U.S.) selected? Were there any cultural frameworks (e.g., individualism-collectivism) considered in their selection? • Since you're using student and fan samples, how comparable are these samples across countries? Are they matched on key demographics (age, gender)? • Was measurement invariance testing (e.g., configural, metric, scalar invariance) considered to formally establish cross-cultural comparability of the CAS-7? • If CAS-7 is found to be "fundamentally unidimensional," how should future researchers treat the subscales — still interpret separately or focus mainly on the total score? • If CAS-7 shows poor fit in certain countries, would you recommend culturally adapting it, or would you suggest developing entirely new culturally sensitive scales? Comments on the methods • The word “database” sounds strange when referring to people (line 168). Consider replacing it with "sample" or "dataset". • You mention the 3 ES and 4 IPBP items but don't explain what ES and IPBP stand for here. This should be briefly expanded for clarity. Questions for the Authors on methods: • Convenience sampling inherently limits generalizability, but this limitation is not acknowledged. It should be. • How many participants came from each country/sample (students vs general population vs celebrity fans)? • Was the sample distribution approximately equal across groups, or heavily skewed toward one? • It is unclear why data access dates are different from data collection dates. o Line 182–183: "The data for research purposes were accessed between 31/12/2015 and 12/04/2024." But participants were recruited starting from 2018. Why access data from 2015? o Please clarify whether there were existing datasets before new data collection started. • Other than age and gender, were any other sociodemographic variables collected (e.g., education, income, country of residence)? If yes, mention them. • Why is this large sample appropriate for CFA and SEM? (A brief note would strengthen the methods section.) • Why are the data access dates (starting from 2015) earlier than the participant recruitment dates (2018)? Were earlier datasets used? Please clarify. • Since participants were from five different countries, was the CAS-7 translated into local languages? • Could you please define ES and IPBP when first introducing them? It will help readers unfamiliar with the original CAS structure. Comments on the discussion • Ideas sometimes jump between results, limitations, and broader interpretations without clear transitions. Use more structured subsections or clearer paragraph transitions. • The claim that CAS-7 “may be widely applicable” (lines 310–311) feels overstated, especially given the cross-cultural limitations admitted. Temper this language to avoid implying broader validity than supported. • The Iranian sample's deviation is mentioned but not discussed in depth. Elaborate more on why the Iranian sample's results differed—was it sample size, cultural interpretation of celebrity, translation issues, etc.? • Some sentences are awkward or confusing, particularly around lines 288–293. Example: “Looking at the term ‘celebrity’, it may have a different meaning across cultures.” Reword to, e.g., "The concept of 'celebrity' itself may vary considerably across cultures, influencing how celebrity admiration is experienced and reported." • Besides research, could CAS-7 be used for clinical, media, or public health purposes in different countries? Briefly discuss practical applications and caution about their limitations due to cultural variability. • It’s unclear how different participant sources (students, general public, celebrity fans) might have influenced the findings. Reflect briefly on whether sample type (beyond nationality) may have introduced additional variability. Questions for the Authors on the discussion: • What are your hypotheses for why the two-factor model did not fit well for the Iranian sample? Could it be related to cultural norms about fame or admiration? • Were there particular CAS-7 items that performed inconsistently across cultures? If yes, which ones and why might that be? [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors, I found your work invaluable and a timely issue however I have a suggestion for you. Despite mentioned in problem statement slightly, you did not justify 7-point likert scale than a 5-point likert scale. I believe that you need to critically show the rationale of using CAS-7 factor structure with its implications under the method section-measure section. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
<p>A cross-cultural investigation of the short version of the Celebrity Attitude Scale (CAS-7) across five countries PONE-D-24-58562R1 Dear Dr. Zsila, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Osmond Ekwebelem Academic Editor PLOS ONE Additional Editor Comments (optional): Comments and questions raised were thoroughly addressed. |
| Formally Accepted |
|
PONE-D-24-58562R1 PLOS ONE Dear Dr. Zsila, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Osmond Ekwebelem Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .